CD4 and breast cancer: In conclusion, we found the unique tumor immune composition resulting from the absence of Ing4 in mammary tumors, consisting of decreased CD4 CTLs indicative of an immune-evasive TME, correlating with increased penetrance (fitness for survival) and metastasis.